Thermo Fisher Scientific Inc (TMO): Today's Featured Health Services Winner - TheStreet

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

.

Thermo Fisher Scientific

(

TMO

) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.9%. By the end of trading, Thermo Fisher Scientific rose 72 cents (1.2%) to $59.44 on light volume. Throughout the day, 1.1 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 1.9 million shares. The stock ranged in a price between $58.85-$59.63 after having opened the day at $58.85 as compared to the previous trading day's close of $58.72. Other companies within the Health Services industry that increased today were:

Allied Healthcare Products

(

AHPI

), up 12.6%,

USMD Holdings

(

USMD

), up 11.2%,

Dynatronics Corporation

(

DYNT

), up 10.5%, and

CHINA NUOKANG BIO-PHARMACEUTICAL

(

NKBP

), up 10.5%.

  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $21.57 billion and is part of the

health care

sector. The company has a P/E ratio of 19.6, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 31.2% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, attractive valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!

Free download now

.

null